According to the research report, the global angiogenesis inhibitor and stimulators market was valued at USD 27.61 billion in 2022 and is expected to reach USD 67.17 billion by 2032, to grow at a CAGR of 9.3% during the forecast period.
According to the research report, the global angiogenesis inhibitor and stimulators market was valued at USD 27.61 billion in 2022 and is expected to reach USD 67.17 billion by 2032, to grow at a CAGR of 9.3% during the forecast period.